60 units of tirzepatide: how many mg does that equal?

Picture the moment: pen in hand, two numbers, one question

You're sitting with a Mounjaro 7.5 mg KwikPen in your hand. Your prescription says 7.5 mg. The dial on the pen counts up in units. A quick text from a friend on the same medicine mentions she's on "60 units." Are you taking the same dose? Yes, exactly the same.

The KwikPen was designed to make self-injection straightforward, but its unit-based dial can create confusion when written guidance, prescriptions and conversations mix milligrams with units. The conversion is fixed: 1 unit = 0.125 mg of tirzepatide. That ratio holds across every Mounjaro strength, from the 2.5 mg starter pen right through to 15 mg. So 60 units always equals 7.5 mg, no exceptions, no rounding.

If you want to check the arithmetic for a different strength, the 7.5 mg units breakdown walks through the same logic in the other direction, which can be useful if your prescription states milligrams and you're trying to confirm where to stop the dial.

One thing worth knowing: the pen contains four weekly doses. You don't draw up 60 units from a vial, you press the injector and the pen delivers the pre-set dose automatically. The unit markings tell you where the pen is in its cycle, not how much liquid you're measuring by hand. That distinction matters for anyone who has previously used insulin pens, where the workflow is different.

Where 7.5 mg sits in the tirzepatide dose schedule

Mounjaro's UK licence covers six strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg, each delivered as a once-weekly subcutaneous injection. Titration is stepwise, typically moving up every four weeks if the previous dose was tolerated, the prescriber decides the pace, not a fixed calendar. The 2.5 mg starting dose (20 units) exists to let your body adjust; the 5 mg dose (40 units) is the next step.

At 7.5 mg (60 units) you're at the midpoint of the schedule. For some people this is the maintenance dose their prescriber settles on; for others it's a stepping stone toward 10 mg or beyond. Neither outcome is better in the abstract, what matters is how your body responds and what your clinician judges appropriate for you. The 5 mg pen page covers 40 units if you've recently stepped up from there and want to see the comparison.

The clinical evidence underpinning this schedule comes from the SURMOUNT programme, published in the New England Journal of Medicine. Dose-response data across thousands of participants showed that higher doses produced greater average weight reduction, which is why the titration exists rather than simply starting at the maximum. The NHS's tirzepatide medicines page summarises the licensed use and side-effect profile for patients.

It's also worth knowing how 7.5 mg compares numerically to what sits either side of it. Thirty units equals 3.75 mg, that's not a licensed Mounjaro dose, but people sometimes see references to 30 units in the context of half-dose discussions; the page there explains why splitting doses isn't clinically recommended. And 10 units converts to just 1.25 mg, which sits below even the starter strength.

Why you should never adjust your dose based on a units-to-mg calculation

This page answers a specific maths question, and that's genuinely useful information to have. But understanding the conversion doesn't mean you can use it to choose a different dose. Tirzepatide is a prescription-only medicine; every change to your dose, including going up, going down or pausing, requires clinical review. That's not a bureaucratic hurdle, it's how serious side effects get caught and how your progress is tracked against the evidence base.

Prescribers reviewing dose increases at a regulated service like ours check weight evidence, tolerability and clinical indicators before authorising the next step. At every repeat order, the consultation is reviewed again by a GPhC-registered Independent Prescriber. A real clinician looks at your record each time, not software.

If you're on 7.5 mg and finding it hard to tolerate, or if you're unsure whether your pen is dialling correctly, the right route is your prescribing team, not a units table. The Patient Information Leaflet inside your pen box is the definitive guide to injection technique, storage and what to do if you miss a dose. NICE's appraisal of tirzepatide (TA1026) also sets out the clinical criteria under which the medicine is recommended, which is useful context if you're thinking about what continued treatment looks like.

If questions about cost or what treatment involves are on your mind too, the weight-loss treatment overview covers both the clinical and practical sides in one place.

When you're ready to speak to a prescriber, check your eligibility through a free consultation, a clinician will review your details the same day.